Literature DB >> 22187447

What can genetic studies of left ventricular mass tell us?

Christopher Newton-Cheh.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22187447      PMCID： PMC3247759          DOI： 10.1161/CIRCGENETICS.111.961839

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN： 1942-3268


× No keyword cloud information.
  16 in total

1.  Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left ventricular mass.

Authors:  B M Mayosi; B Keavney; A Kardos; C H Davies; P J Ratcliffe; M Farrall; H Watkins
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

2.  Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men.

Authors:  J Sundström; L Lind; J Arnlöv; B Zethelius; B Andrén; H O Lithell
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

3.  Insulin regulation of heart function in aging fruit flies.

Authors:  Robert J Wessells; Erin Fitzgerald; James R Cypser; Marc Tatar; Rolf Bodmer
Journal:  Nat Genet       Date:  2004-11-21       Impact factor: 38.330

4.  Myostatin, the cardiac chalone of insulin-like growth factor-1.

Authors:  Vinciane Gaussin; Christophe Depre
Journal:  Cardiovasc Res       Date:  2005-10-13       Impact factor: 10.787

5.  Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; W P Castelli; J R Margolis
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.

Authors:  P M Okin; R B Devereux; S Jern; S E Kjeldsen; S Julius; B Dahlöf
Journal:  Hypertension       Date:  2000-11       Impact factor: 10.190

8.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

9.  Common variants at ten loci influence QT interval duration in the QTGEN Study.

Authors:  Christopher Newton-Cheh; Mark Eijgelsheim; Kenneth M Rice; Paul I W de Bakker; Xiaoyan Yin; Karol Estrada; Joshua C Bis; Kristin Marciante; Fernando Rivadeneira; Peter A Noseworthy; Nona Sotoodehnia; Nicholas L Smith; Jerome I Rotter; Jan A Kors; Jacqueline C M Witteman; Albert Hofman; Susan R Heckbert; Christopher J O'Donnell; André G Uitterlinden; Bruce M Psaty; Thomas Lumley; Martin G Larson; Bruno H Ch Stricker
Journal:  Nat Genet       Date:  2009-03-22       Impact factor: 38.330

10.  Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies.

Authors:  Brendan J Keating; Sam Tischfield; Sarah S Murray; Tushar Bhangale; Thomas S Price; Joseph T Glessner; Luana Galver; Jeffrey C Barrett; Struan F A Grant; Deborah N Farlow; Hareesh R Chandrupatla; Mark Hansen; Saad Ajmal; George J Papanicolaou; Yiran Guo; Mingyao Li; Stephanie Derohannessian; Paul I W de Bakker; Swneke D Bailey; Alexandre Montpetit; Andrew C Edmondson; Kent Taylor; Xiaowu Gai; Susanna S Wang; Myriam Fornage; Tamim Shaikh; Leif Groop; Michael Boehnke; Alistair S Hall; Andrew T Hattersley; Edward Frackelton; Nick Patterson; Charleston W K Chiang; Cecelia E Kim; Richard R Fabsitz; Willem Ouwehand; Alkes L Price; Patricia Munroe; Mark Caulfield; Thomas Drake; Eric Boerwinkle; David Reich; A Stephen Whitehead; Thomas P Cappola; Nilesh J Samani; A Jake Lusis; Eric Schadt; James G Wilson; Wolfgang Koenig; Mark I McCarthy; Sekar Kathiresan; Stacey B Gabriel; Hakon Hakonarson; Sonia S Anand; Muredach Reilly; James C Engert; Deborah A Nickerson; Daniel J Rader; Joel N Hirschhorn; Garret A Fitzgerald
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240
View more
  1 in total

1.  Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension.

Authors:  Katja Grabowski; Laura Herlan; Anika Witten; Fatimunnisa Qadri; Andreas Eisenreich; Diana Lindner; Martin Schädlich; Angela Schulz; Jana Subrova; Ketaki Nitin Mhatre; Uwe Primessnig; Ralph Plehm; Sophie van Linthout; Felicitas Escher; Michael Bader; Monika Stoll; Dirk Westermann; Frank R Heinzel; Reinhold Kreutz
Journal:  Hypertens Res       Date:  2021-12-16       Impact factor: 3.872
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.